Allele Biotechnology and Pharmaceuticals, Inc. v. Regeneron Pharmaceuticals, Inc.
Opinion
Case: 25-1117 Document: 13 Page: 1 Filed: 12/31/2024
NOTE: This order is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________
ALLELE BIOTECHNOLOGY AND
PHARMACEUTICALS, INC.,
Plaintiff-Appellee v.
REGENERON PHARMACEUTICALS, INC.,
Defendant-Appellant ______________________
2025-1117 ______________________
Appeal from the United States District Court for the Southern District of New York in No. 7:20-cv-08255-PMH, Judge Philip M. Halpern. ______________________
ORDER
The parties having so agreed, it is ordered that: (1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b).
Case: 25-1117 Document: 13 Page: 2 Filed: 12/31/2024
2 ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, INC. V. REGENERON PHARMACEUTICALS, INC.
(2) Each side shall bear their own costs.
FOR THE COURT
December 31, 2024
Date
ISSUED AS A MANDATE: December 31, 2024
Case-law data current through September 30, 2026. Source: CourtListener bulk data.